FDA, Researchers Flag Safety Problems With Vena Cava Filters
This article was originally published in The Gray Sheet
Executive Summary
FDA is warning clinicians about long-term use of certain retrievable embolism-protection filters after receiving nearly 1,000 adverse event reports about the devices